MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price to Book Value : 2.887 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.921 |
| August 20, 2026 | 2.901 |
| August 19, 2026 | 3.002 |
| August 18, 2026 | 2.928 |
| August 17, 2026 | 2.827 |
| August 14, 2026 | 2.881 |
| August 13, 2026 | 2.834 |
| August 12, 2026 | 2.888 |
| August 11, 2026 | 2.914 |
| August 10, 2026 | 2.881 |
| August 07, 2026 | 2.928 |
| August 06, 2026 | 2.82 |
| August 05, 2026 | 2.806 |
| August 04, 2026 | 2.881 |
| August 03, 2026 | 2.881 |
| July 31, 2026 | 2.786 |
| July 30, 2026 | 2.881 |
| July 29, 2026 | 2.854 |
| July 28, 2026 | 2.941 |
| July 27, 2026 | 2.874 |
| July 24, 2026 | 2.834 |
| July 23, 2026 | 2.786 |
| July 22, 2026 | 2.813 |
| July 21, 2026 | 2.914 |
| July 20, 2026 | 2.921 |
| Date | Value |
|---|---|
| July 17, 2026 | 2.901 |
| July 16, 2026 | 2.989 |
| July 15, 2026 | 2.881 |
| July 14, 2026 | 2.834 |
| July 13, 2026 | 2.752 |
| July 10, 2026 | 2.773 |
| July 09, 2026 | 2.793 |
| July 08, 2026 | 2.874 |
| July 07, 2026 | 2.834 |
| July 06, 2026 | 2.746 |
| July 02, 2026 | 2.665 |
| July 01, 2026 | 2.631 |
| June 30, 2026 | 2.597 |
| June 29, 2026 | 2.397 |
| June 26, 2026 | 2.409 |
| June 25, 2026 | 2.336 |
| June 24, 2026 | 2.348 |
| June 23, 2026 | 2.287 |
| June 22, 2026 | 2.250 |
| June 18, 2026 | 2.250 |
| June 17, 2026 | 2.213 |
| June 16, 2026 | 2.268 |
| June 15, 2026 | 2.256 |
| June 12, 2026 | 2.207 |
| June 11, 2026 | 2.262 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.077 |
| Perspective Therapeutics, Inc. | 1.120 |
| ABVC BioPharma, Inc. | 2.115 |
| Enovis Corp. | 0.9846 |
| Edwards Lifesciences Corp. | 4.915 |
Price to Book Value Related Metrics
| PE Ratio | 108.35 |
| PS Ratio | 1.796 |
| Price to Free Cash Flow | 15.07 |
| Price | 4.28 |
| Earnings Yield | 0.92% |
| Market Cap | 623.70M |
| Operating PE Ratio | 72.88 |
| Normalized PE Ratio | 108.63 |